186 related articles for article (PubMed ID: 34104651)
1. The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma.
Geng C; Yang G; Wang H; Zhang Z; Zhou H; Chen W
Biomed Res Int; 2021; 2021():6689457. PubMed ID: 34104651
[TBL] [Abstract][Full Text] [Related]
2. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
[TBL] [Abstract][Full Text] [Related]
3. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT).
Zhang L; Ye J; Luo Q; Kuang M; Mao M; Dai S; Wang X
Cancer Manag Res; 2020; 12():5373-5384. PubMed ID: 32753955
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of routine coagulation tests for patients with heat stroke.
Xing L; Liu SY; Mao HD; Zhou KG; Song Q; Cao QM
Am J Emerg Med; 2021 Jun; 44():366-372. PubMed ID: 32389399
[TBL] [Abstract][Full Text] [Related]
6. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
7. Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients.
Geng C; Yang G; Wang H; Wu Y; Leng Y; Zhou H; Zhang Z; Jian Y; Chen W
Leuk Lymphoma; 2021 Apr; 62(4):883-890. PubMed ID: 33275060
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.
Chen J; Phillips B; Chandler WL
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):90-6. PubMed ID: 26397883
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent era.
Geng C; Yang G; Zhou H; Wang H; Li Y; Leng Y; Zhang Z; Jian Y; Chen W
Hematology; 2023 Dec; 28(1):2161222. PubMed ID: 36607148
[TBL] [Abstract][Full Text] [Related]
10. Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival.
Qi Y; Fu J
J BUON; 2017; 22(2):462-467. PubMed ID: 28534370
[TBL] [Abstract][Full Text] [Related]
11. Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis.
Yuan Y; Li X; Qiu F
Clin Appl Thromb Hemost; 2023; 29():10760296231178546. PubMed ID: 37271988
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
13. The coagulation profile of preterm delivery.
Keren-Politansky A; Breizman T; Brenner B; Sarig G; Drugan A
Thromb Res; 2014 Apr; 133(4):585-9. PubMed ID: 24508451
[TBL] [Abstract][Full Text] [Related]
14. [Coagulation Indexes and Their Prognostic Significance in Patients with Multiple Myeloma].
Li QF; Zhang QK; Wei XF; Feng YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):791-796. PubMed ID: 34105474
[TBL] [Abstract][Full Text] [Related]
15. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
[TBL] [Abstract][Full Text] [Related]
16. Coagulation tests on admission correlate with mortality and morbidity in general ICU patients: An observational study.
Benediktsson S; Hansen C; Frigyesi A; Kander T
Acta Anaesthesiol Scand; 2020 May; 64(5):628-634. PubMed ID: 31898318
[TBL] [Abstract][Full Text] [Related]
17. Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests.
Cho HJ; Kang YJ; Sung SM; Ahn SH; Jung YH; Lee KY; Seo JH; Han SW; Park JH; Choi HY; Kwon JH; Kim WJ; Park HJ; Choi JK; Nam HS; Heo JH; Kim YD
PLoS One; 2020; 15(10):e0240483. PubMed ID: 33044991
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic relationship between CD56 expression and newly diagnosed multiple myeloma].
Geng CY; Yang GZ; Wang HJ; Zhou HX; Zhang ZY; Jian Y; Chen WM
Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):164-171. PubMed ID: 35090251
[No Abstract] [Full Text] [Related]
19. Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome.
Idowu OE; Oyeleke SO; Vitowanu JM
Eur J Trauma Emerg Surg; 2022 Apr; 48(2):1085-1092. PubMed ID: 33839805
[TBL] [Abstract][Full Text] [Related]
20. Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults.
Miljic D; Miljic P; Doknic M; Pekic S; Djurovic M; Colovic M; Popovic V
Hormones (Athens); 2006; 5(3):187-91. PubMed ID: 16950752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
